Peter Heerma

Insider Reports History

Location
San Diego, CA
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Heerma:

Company Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Common Stock 131,823 $4,234,154 $32.12 03 Feb 2026 Direct
Travere Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Performance-based restricted stock units 4,920 $0 $23.53 02 May 2025 Direct
Travere Therapeutics, Inc. CHIEF COMMERCIAL OFFICER Employee stock option (right to buy) 69,640 31 Jan 2026 Direct

Insider Reports Filed by Peter Heerma

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TVTX Travere Therapeutics, Inc. 31 Jan 2026 3 -$234,797 4 CHIEF COMMERCIAL OFFICER 03 Feb 2026, 21:30
TVTX Travere Therapeutics, Inc. 24 Dec 2025 1 -$199,200 4 CHIEF COMMERCIAL OFFICER 29 Dec 2025, 21:11
TVTX Travere Therapeutics, Inc. 31 Oct 2025 2 -$195,685 4 CHIEF COMMERCIAL OFFICER 04 Nov 2025, 16:05
TVTX Travere Therapeutics, Inc. 28 Oct 2025 1 -$79,860 4 CHIEF COMMERCIAL OFFICER 30 Oct 2025, 16:45
TVTX Travere Therapeutics, Inc. 23 Sep 2025 1 $0 4 CHIEF COMMERCIAL OFFICER 24 Sep 2025, 16:05
TVTX Travere Therapeutics, Inc. 02 May 2025 3 -$37,280 4 CHIEF COMMERCIAL OFFICER 05 May 2025, 21:53
TVTX Travere Therapeutics, Inc. 10 Feb 2025 4 -$137,276 4 CHIEF COMMERCIAL OFFICER 12 Feb 2025, 21:25
TVTX Travere Therapeutics, Inc. 31 Jan 2025 3 -$103,940 4 CHIEF COMMERCIAL OFFICER 04 Feb 2025, 20:30
TVTX Travere Therapeutics, Inc. 22 Jan 2025 1 -$30,002 4 CHIEF COMMERCIAL OFFICER 23 Jan 2025, 20:35
TVTX Travere Therapeutics, Inc. 05 Sep 2024 2 -$25,240 4 CHIEF COMMERCIAL OFFICER 09 Sep 2024, 21:20
TVTX Travere Therapeutics, Inc. 31 Jan 2024 3 -$35,789 4 CHIEF COMMERCIAL OFFICER 02 Feb 2024, 16:05
TVTX Travere Therapeutics, Inc. 23 Jan 2024 1 -$14,138 4 CHIEF COMMERCIAL OFFICER 25 Jan 2024, 16:10
TVTX Travere Therapeutics, Inc. 03 Oct 2023 1 -$25,504 4 Chief Commercial Officer 04 Oct 2023, 16:05
TVTX Travere Therapeutics, Inc. 31 Jan 2023 4 -$38,697 4 Chief Commercial Officer 02 Feb 2023, 18:04
TVTX Travere Therapeutics, Inc. 24 Jan 2023 1 -$33,952 4 Chief Commercial Officer 26 Jan 2023, 15:05
TVTX Travere Therapeutics, Inc. 04 Oct 2022 1 -$78,119 4 Chief Commercial Officer 06 Oct 2022, 20:10
TVTX Travere Therapeutics, Inc. 31 Jan 2022 5 -$30,825 4 Chief Commercial Officer 02 Feb 2022, 15:18
TVTX Travere Therapeutics, Inc. 24 Jan 2022 1 -$46,838 4 Chief Commercial Officer 26 Jan 2022, 15:36
TVTX Travere Therapeutics, Inc. 04 Oct 2021 1 -$75,746 4 Chief Commercial Officer 05 Oct 2021, 16:06
TVTX Travere Therapeutics, Inc. 13 Aug 2021 2 -$24,086 4 Chief Commercial Officer 17 Aug 2021, 19:41